Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-30

Clinical Trial Update: Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol [Phase 1]

View source ↗

Summary

This document provides an update on the Phase 1 clinical trial protocol for pazufloxacin mesilate ear drops to treat otitis media.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazufloxacin mesilate ear drops (pazufloxacin mesilate)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Otitis Media | Phase 1 | Status: UNKNOWN